Alzheimer’s Prevention Trials—The Future Looks Promising

Alzheimer’s Prevention Trials—The Future Looks Promising

While there is active research for more effective disease-modifying drugs* the lack of any significant breakthroughs in the treatment of the Alzheimer’s disease has propelled a paradigm shift away from focusing solely on a drug solution, to an inclusive prevention model that emphasizes risk reduction and prevention, which promises to attenuate the portentous global burden incurred by the disease.

Current prevalence estimates (2016) for late-onset Alzheimer’s disease (LOAD) in the United States (U.S.) is approximately 5.1 million.(1) By 2050 the projected prevalence of LOAD is expected to escalate to 13.8 million and a staggering 106.8 million worldwide.(2,3) Pharmacological treatments for LOAD such as cholinesterase inhibitors and NMDA receptor antagonists may slow its progression or attenuate specific molecular pathomechanisms associated with the disease process, but are not long term solutions or curative.
(more…)

MEMBER ACCESS: Mercury Depletes Glutathione Peroxidase-Toxic Mechanisms In Alzheimer’s Disease Risk

MEMBER ACCESS: Mercury Depletes Glutathione Peroxidase-Toxic Mechanisms In Alzheimer’s Disease Risk

The research demonstrating the deleterious and toxic effects of mercury on brain function and struct...

Members Only

This is member access content and is available with a free Brainy member registration.

If you have already registered, please login below.

If you have not setup your free lifetime membership you can learn more and register for access along with my newsletter here.

 

MEMBER  ACCESS: TREM2 genetic variants in Alzheimer’s disease

MEMBER ACCESS: TREM2 genetic variants in Alzheimer’s disease

By Ralph Sanchez, MTCM, CNS, D.Hom.
Two recently published studies (2013) on a rare variant of the ...

Members Only

This is member access content and is available with a free Brainy member registration.

If you have already registered, please login below.

If you have not setup your free lifetime membership you can learn more and register for access along with my newsletter here.

 

MEMBER ACCESS: The Alzheimer’s Gene Puzzle—The ApoE4 Variant As A Risk Factor

MEMBER ACCESS: The Alzheimer’s Gene Puzzle—The ApoE4 Variant As A Risk Factor

By Ralph Sanchez, L.Ac.,CNS,D.Hom

Genetic risk factors to late-onset Alzheimer's disease (LOAD) a...

Members Only

This is member access content and is available with a free Brainy member registration.

If you have already registered, please login below.

If you have not setup your free lifetime membership you can learn more and register for access along with my newsletter here.

 

Pin It on Pinterest